Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Revolo Biotherapeutics

Request full access

Developing revolutionary therapies powered to reset the immune system to achieve superior long-term remission for patients with autoimmune and allergic diseases

Gaithersburg, United StatesFounded 2011Biotech & Life Sciences

About Revolo Biotherapeutics

Revolo Biotherapeutics is a pioneering biotherapeutics company focused on transforming the treatment landscape for autoimmune and allergic diseases. The company develops innovative therapies designed to reset the immune system, aiming for long-term disease remission after just a single administration. Revolo Biotherapeutics serves patients suffering from various autoimmune and allergic conditions, operating within the biopharmaceutical market. The company's business model revolves around drug discovery and development, leveraging its unique disease-agnostic approach to create groundbreaking treatments. Revenue is generated through the development and commercialization of these therapies, as well as potential partnerships and licensing agreements. With headquarters in Gaithersburg, MD, USA, and London, UK, Revolo Biotherapeutics has a global footprint and is led by a team of seasoned experts in immunology and biopharmaceuticals.

Source: Dealroom company data

At a glance

Status
Operational
Employees
19
Open positions
None listed
Dealroom signal
38.2/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B, B2C

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BOther financing Sep 2020 $54M $214M Morningside · Metellus · 24Haymarket —
SERIES AOther financing Nov 2018 $0 — 24Haymarket · NCL Technology Ventures —
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Financials

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearEBITDAMargin
2026 —
2025 —
2024 —
2023 —
2022 —
2021 —
2020 —
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Revolo Biotherapeutics website traffic

Latest recorded traffic for Revolo Biotherapeutics is 180 monthly website visits, up 125% over the last three months. Revolo Biotherapeutics's team declined 5% over the past year.

Latest monthly visits180 3-month web change+125% 1-year team growth-5%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Revolo Biotherapeutics in the Gaithersburg ecosystem

Live from Dealroom

The Revolo Biotherapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • NCL Technology Ventures

Series A3 investors entered at this stage

Other known investors1 additional known investor

  • Oregon Health & Science University
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇺🇸 United States57.1%
🇬🇧 United Kingdom35.7%
🇨🇭 Switzerland7.1%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Revolo Biotherapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Revolo Biotherapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.